Pharmaceutical Giants Bet on Booming Obesity Market Amid Rising Health Concerns
Published on: Sept. 23, 2025, 2:33 a.m. | Source: Devdiscourse
Roche enters the obesity drug market, advancing a treatment to late-stage trials. Omnicare files for bankruptcy amid litigation. Pfizer acquires Metsera for $7.3 billion to expand its weight-loss portfolio. Mexico confirms a screwworm case near the U.S. border. Poland reports a bird flu outbreak affecting poultry farms.
